ClinicalTrials.Veeva

Menu

The Performances of Spectral Domain Optical Coherence Tomography (OCT) for Distinguishing Glaucomatous Eyes (cirrusOCT)

P

Prince of Songkla University

Status

Completed

Conditions

Glaucoma Suspect Patient
RNFL Thickness by Location
Normal Population
Macular Thickness by Location
Glaucoma Patient

Study type

Observational

Funder types

Other

Identifiers

NCT01067482
EC 52-336-02-1-2

Details and patient eligibility

About

The purpose of this study is to evaluate performances of each parameters of spectral domain (Cirrus) optical coherence tomography for distinguishing between normal eyes, glaucoma suspect and glaucomatous eyes

Full description

Aim to determine which parameter of cirrus OCT is best sensitivity and specificity for glaucoma detection

Enrollment

80 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • BCVA at least 20/60
  • refractive error +/- 5 D Or astig +/- 3 D
  • enrolled in 3 population group (glaucoma, glaucoma suspect or normal)

Exclusion criteria

  • VA less than 20/60
  • marked RF error
  • previous ocular trauma or surgery
  • unreliable visual field
  • poor signal cirrus OCT (less than 7)
  • other causes of optic nerve or macular disease other than glaucoma

Trial design

80 participants in 3 patient groups

Glaucoma patients
Glaucoma suspect group
Normal population

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems